These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22104553)

  • 21. [Evaluation for antithrombotic agents by a thrombotic model in animals].
    Suzuki Y
    Yakugaku Zasshi; 2012; 132(9):1019-24. PubMed ID: 23023418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse model of in situ thromboembolic stroke and reperfusion.
    Orset C; Macrez R; Young AR; Panthou D; Angles-Cano E; Maubert E; Agin V; Vivien D
    Stroke; 2007 Oct; 38(10):2771-8. PubMed ID: 17702959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversing the deleterious effects of α2-antiplasmin on tissue plasminogen activator therapy improves outcomes in experimental ischemic stroke.
    Houng AK; Wang D; Reed GL
    Exp Neurol; 2014 May; 255():56-62. PubMed ID: 24556477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury.
    Sullivan BP; Kassel KM; Jone A; Flick MJ; Luyendyk JP
    Am J Pathol; 2012 Jun; 180(6):2321-9. PubMed ID: 22507835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.
    Song HY; Chung JI; Jalin AMA; Ju C; Pahk K; Joung C; Lee S; Jin S; Kim BS; Lee KS; Ryu JM; Kim WK
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of TAFI increases brain damage and microparticle generation after thrombolytic therapy in ischemic stroke.
    Orbe J; Alexandru N; Roncal C; Belzunce M; Bibiot P; Rodriguez JA; Meijers JC; Georgescu A; Paramo JA
    Thromb Res; 2015 Aug; 136(2):445-50. PubMed ID: 26118976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
    Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel mouse model of thromboembolic stroke.
    Chen Y; Zhu W; Zhang W; Libal N; Murphy SJ; Offner H; Alkayed NJ
    J Neurosci Methods; 2015 Dec; 256():203-11. PubMed ID: 26386284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiologic variations in blood plasminogen levels affect outcomes after acute cerebral thromboembolism in mice: a pathophysiologic role for microvascular thrombosis.
    Singh S; Houng AK; Wang D; Reed GL
    J Thromb Haemost; 2016 Sep; 14(9):1822-32. PubMed ID: 27319402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse model of microembolic stroke and reperfusion.
    Atochin DN; Murciano JC; Gürsoy-Ozdemir Y; Krasik T; Noda F; Ayata C; Dunn AK; Moskowitz MA; Huang PL; Muzykantov VR
    Stroke; 2004 Sep; 35(9):2177-82. PubMed ID: 15256680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage.
    Navarro-Oviedo M; Marta-Enguita J; Roncal C; Rodríguez JA; Zandio B; Lecumberri R; Hermida J; Oyarzabal J; Pineda-Lucena A; Páramo JA; Muñoz R; Orbe J
    Thromb Haemost; 2022 Aug; 122(8):1314-1325. PubMed ID: 35114692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain injury and cerebrovascular fibrin deposition correlate with reduced antithrombotic brain capillary functions in a hypertensive stroke model.
    Ninomia T; Wang L; Kumar SR; Kim A; Zlokovic BV
    J Cereb Blood Flow Metab; 2000 Jun; 20(6):998-1009. PubMed ID: 10894183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.
    Saleem S; Wang D; Zhao T; Sullivan RD; Reed GL
    Neuroscience; 2021 Apr; 460():120-129. PubMed ID: 33465414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic stroke.
    Kraft P; Schwarz T; Meijers JC; Stoll G; Kleinschnitz C
    PLoS One; 2010 Jul; 5(7):e11658. PubMed ID: 20657835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.
    Nagashima M; Werner M; Wang M; Zhao L; Light DR; Pagila R; Morser J; Verhallen P
    Thromb Res; 2000 May; 98(4):333-42. PubMed ID: 10822080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.
    Simão F; Ustunkaya T; Clermont AC; Feener EP
    Blood; 2017 Apr; 129(16):2280-2290. PubMed ID: 28130211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No increased systemic fibrinolysis in women with heavy menstrual bleeding.
    Wiewel-Verschueren S; Knol HM; Lisman T; Bogchelman DH; Kluin-Nelemans JC; van der Zee AG; Mulder AB; Meijer K
    J Thromb Haemost; 2014 Sep; 12(9):1488-93. PubMed ID: 24954113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
    Singh S; Houng A; Reed GL
    Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
    Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
    Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microvascular thrombosis, fibrinolysis, ischemic injury, and death after cerebral thromboembolism are affected by levels of circulating α2-antiplasmin.
    Reed GL; Houng AK; Wang D
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2586-93. PubMed ID: 25256235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.